Evidence map›Paper›PMID 16846342›Full record

Trial reportTissue engineering2006

Effect of rhPDGF-BB delivery on mediators of periodontal wound repair.

Jason W Cooke, David P Sarment, Louis A Whitesman, Sarah E Miller, Qiming Jin, Samuel E Lynch, William V Giannobile

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Tissue engineering, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Effect of rhPDGF-BB on bone turnover during periodontal repair.Journal of clinical periodontology · 2006
    Trial
  9. Review
  10. Review
  11. Wound fluid sampling methods for proteomic studies: A scoping review.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Biomaterial selection for tooth regeneration.Tissue engineering. Part B, Reviews · 2011
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jason W CookeDepartment of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, Michigan, USA.
David P Sarment
Louis A Whitesman
Sarah E Miller
Qiming Jin
Samuel E Lynch
William V Giannobile
University of Michigan–Ann Arbor · USMichigan Center for Translational Pathology · US

Funding

GENE THERAPY FOR RECONSTRUCTING PERIODONTAL TISSUESR01DE013397 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIANNOBILE, WILLIAM V · 2000 to 2014
$4.0M
STUDENTS IN HEALTH PROFESSIONAL SCHOOLST35DE007101 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHIEGO, DANIEL J · 1985 to 2004
$310k
NIDCR NIH HHS R01 DE013397NIDCR NIH HHS R01-DE13397NIDCR NIH HHS T35 DE007101NIDCR NIH HHS T-35DE07101
6 · The paper itself

Abstract

Growth factors such as platelet-derived growth factor (PDGF) exert potent effects on wound healing including the regeneration of tooth-supporting structures. This investigation examined the effect of the local delivery of PDGF-BB when combined with reconstructive periodontal surgery on local wound fluid (WF) levels of PDGF-AB, vascular endothelial growth factor (VEGF), and bone collagen telopeptide (ICTP) in humans with advanced periodontitis. Sixteen patients exhibiting localized periodontal osseous defects were randomized to one of three groups (beta-TCP carrier alone, beta-TCP + 0.3 mg/mL of recombinant human PDGF-BB [rhPDGF-BB], or beta-TCP + 1.0 mg/mL of rhPDGF-BB) and monitored for 6 months. WF was harvested and analyzed for PDGF-AB, VEGF, and ICTP WF levels. Teeth contralateral to the target lesions served as controls. Increased levels of VEGF in the WF was observed for all surgical treatment groups with the 1.0 mg/mL rhPDGF-BB group showing the most pronounced difference at 3 weeks in the AUC analysis versus control (p < 0.0001). PDGF-AB WF levels were increased for the carrier alone group compared to both rhPDGFBB groups. Low-dose rhPDGF-BB application elicited increases in ICTP at days 3-5 in the wound healing process, suggesting a promotion of bone turnover at early stages of the repair process (p < 0.02). These results demonstrate contrasting inducible expression patterns of PDGF-AB, VEGF, and ICTP during periodontal wound healing in humans.

Indexed as

Tissue EngineeringAdultAgedBecaplerminCollagen Type IDrug Delivery SystemsFemaleHumansMaleMiddle AgedPeptide FragmentsPeriodontitisPlatelet-Derived Growth FactorProto-Oncogene Proteins c-sisRecombinant ProteinsVascular Endothelial Growth Factor ABecaplerminCollagen Type IPeptide FragmentsPlatelet-Derived Growth FactorProto-Oncogene Proteins c-sisRecombinant ProteinsVascular Endothelial Growth Factor A

Identifiers

PMID16846342
PMCPMC2586965
OpenAlexW2079834185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.